Piper Sandler Maintains Neutral on Staar Surgical, Lowers Price Target to $45
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Matt O'Brien has maintained a Neutral rating on Staar Surgical (NASDAQ:STAA) and lowered the price target from $50 to $45.
September 15, 2023 | 2:15 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Piper Sandler has maintained a Neutral rating on Staar Surgical and lowered the price target from $50 to $45.
The lowering of the price target by Piper Sandler from $50 to $45 indicates a potential decrease in the stock's value. This could lead to a negative short-term impact on Staar Surgical's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100